Saturday, June 7, 2025
HomeTagsOncology Drug Development

Oncology Drug Development

Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI

Pathos AI, a leading AI-driven biotech company applying cutting-edge artificial intelligence to drug development, announced its $365 million Series D financing, bringing its post-money...

Avacta and Tempus Collaborate on AI-Driven Oncology Drug Development

Avacta Therapeutics, a life sciences company developing next generation peptide drug conjugates (PDC) targeting powerful anti-tumor payloads directly to the tumor, announces the initiation...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics